Literature DB >> 18448501

The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level.

N Kamel, C Compton, R Middelveld, T Higenbottam, S-E Dahlén.   

Abstract

Mesh：

Year:  2008        PMID： 18448501     DOI： 10.1183/09031936.00033208

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  6 in total

1.  Time for cooperation in health economics among the modelling community.

Authors:  Renée J G Arnold; Sean Ekins
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  How can we improve the translational landscape for a faster cure of type 1 diabetes?

Authors:  Matthias von Herrath; Andrew Chan
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

Review 3.  Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery.

Authors:  Michael R Barnes; Lee Harland; Steven M Foord; Matthew D Hall; Ian Dix; Scott Thomas; Bryn I Williams-Jones; Cory R Brouwer
Journal:  Nat Rev Drug Discov       Date:  2009-07-17       Impact factor: 84.694

4.  The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedside.

Authors:  Joanne S Luciano; Bosse Andersson; Colin Batchelor; Olivier Bodenreider; Tim Clark; Christine K Denney; Christopher Domarew; Thomas Gambet; Lee Harland; Anja Jentzsch; Vipul Kashyap; Peter Kos; Julia Kozlovsky; Timothy Lebo; Scott M Marshall; Jamie P. McCusker; Deborah L McGuinness; Chimezie Ogbuji; Elgar Pichler; Robert L Powers; Eric Prud'hommeaux; Matthias Samwald; Lynn Schriml; Peter J Tonellato; Patricia L Whetzel; Jun Zhao; Susie Stephens; Michel Dumontier
Journal:  J Biomed Semantics       Date:  2011-05-17

Review 5.  Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?

Authors:  Alexander Schuhmacher; Oliver Gassmann; Nigel McCracken; Markus Hinder
Journal:  J Transl Med       Date:  2018-05-08       Impact factor: 5.531

6.  Integration of patient-reported outcomes in multiregional confirmatory clinical trials.

Authors:  Ari Gnanasakthy; Carla DeMuro; Caroline Boulton
Journal:  Contemp Clin Trials       Date:  2013-02-13       Impact factor: 2.226
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.